Biotech Lock-Up Expiration Hell Portfolio Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: keokalani'nui who wrote (533)	12/11/2001 2:17:00 PM
From: tuck	Read Replies (1) of 1005

Permit me a correction on the impending Bruker AXS IPO. In the latest S-1/A, the underwriters have given a range: 9 million shares offered for $8 - $10 per share, with overallotment option of 1.35 million shares. 53,532,261 shares will be outstanding unless the deal prices below the range, in which case more shares (up to 7.4+ million) could be issued. Guess they feel they need a certain amount. CIBC leading. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next